Ficheux A, Argilés A, Mion H, Mion C M
UDSA-AIDER, Service de Biochimie B, Centre Hospitalier Universitaire "St Eloi," and Institut de Génétique Humaine(IGH)-UPR 1142 CNRS, Montpellier, France.
Kidney Int. 2000 Apr;57(4):1755-63. doi: 10.1038/sj.ki.4495463.
Dialysis efficacy is mostly influenced by dialyzer clearance. Urea clearance may be estimated in vitro by total ion clearance, which can be obtained by conductivity measurements. We have previously used this approach to assess in vitro clearances in a system mimicking predilutional and postdilutional online hemodiafiltration with a wide range of QD, QB, and ultrafiltration rates. Our current study elaborates on a formula that allows the prediction of the influence of ultrafiltration on small molecule clearances, and validates the mathematical approach both experimentally in vitro and clinically in vivo data.
Two conductivimeters in the dialysate side of an E-2008 Fresenius machine were used. HF80 and HF40 polysulfone dialyzers were used; reverse osmosis water and dialysate were used for blood and dialysate compartments, respectively. Study conditions included QB of 300 and 400 mL/min and QD of 500 and 590 mL/min, with a range of ultrafiltration rate from 0 to 400 mL/min in postdilutional hemodiafiltration and to 590 mL/min in predilutional hemodiafiltration. Urea clearances were determined in the in vivo studies, which included 0, 50, 100, and 150 mL/min ultrafiltration rates.
The ultrafiltration rate and clearance were significantly correlated (R > 0.9, P < 0.001) and fitted a linear model (P < 0.001) in all of the experimental conditions. The following formula fitted the experimental points with an error <2% for both postdilutional and predilutional online diafiltration in vitro, respectively. K = K0 + [(QB - K0)/(QB)] x ultrafiltration rateK = K0 + [((QD x QB)/(QB + QD) - K0)/QD] x ultrafiltration rate where K is the clearance; K0 is the clearance with nil ultrafiltration rate; QD is the total dialysate produced (in commercial HDF, QD = QDi + Qinf). Since weight loss was maintained at 0, ultrafiltration rate = infusion flow. QB is the "blood" line flow. The formula was also verified in vivo in clinical postdilutional hemodiafiltration with a QB taking into account the cellular and water compartments.
In vitro, by simply determining the clearance in conventional dialysis, the total clearance for any ultrafiltration rate may be estimated in both predilutional and postdilutional online diafiltration with an error of less than 2%. The same applies to in vivo postdilutional hemodiafiltration when the formula takes into account the cellular and water composition of blood.
透析疗效主要受透析器清除率影响。尿素清除率可通过总离子清除率在体外进行估算,总离子清除率可通过电导率测量获得。我们之前曾使用这种方法在一个模拟预稀释和后稀释在线血液透析滤过的系统中评估体外清除率,该系统具有广泛的透析液流量(QD)、血流量(QB)和超滤率。我们当前的研究详细阐述了一个公式,该公式可预测超滤对小分子清除率的影响,并在体外实验和体内临床数据中验证了该数学方法。
使用费森尤斯E - 2008机器透析液侧的两个电导率仪。使用HF80和HF40聚砜透析器;分别使用反渗透水和透析液作为血液和透析液腔室的液体。研究条件包括QB为300和400 mL/分钟以及QD为500和590 mL/分钟,在后稀释血液透析滤过中超滤率范围为0至400 mL/分钟,在预稀释血液透析滤过中超滤率范围为0至590 mL/分钟。在体内研究中测定尿素清除率,体内研究包括超滤率为0、50、100和150 mL/分钟。
在所有实验条件下,超滤率与清除率显著相关(R > 0.9,P < 0.001),并符合线性模型(P < 0.001)。以下公式分别以小于2%的误差拟合了后稀释和预稀释在线透析滤过的实验点。
K = K0 + [(QB - K0)/(QB)]×超滤率
K = K0 + [((QD×QB)/(QB + QD) - K0)/QD]×超滤率
其中K为清除率;K0为超滤率为零时的清除率;QD为产生的总透析液量(在商业血液透析滤过中, QD = QDi + Qinf)。由于体重减轻维持在0,超滤率 = 输液流量。QB为“血液”管路流量。该公式在考虑细胞和水腔室的体内临床后稀释血液透析滤过中也得到了验证。
在体外,通过简单测定传统透析中的清除率,可在预稀释和后稀释在线透析滤过中估算任何超滤率下的总清除率,误差小于2%。当公式考虑血液的细胞和水成分时,这同样适用于体内后稀释血液透析滤过。